A six-week online self-management program for adults in Israel with chronic conditions
Official title: Implementation of a Self-Management Support Program Among People With Kidney Transplant and Cancer Survivors in Israel: Testing Feasibility and Effects
Run by University of Haifa · NCT07367750 · Data updated 2026-11-12
This six-week online group program will try to help adults in Israel who have chronic conditions—such as cancer survivors or kidney transplant recipients—learn practical skills to manage symptoms and daily health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 45 (estimated) |
| Sponsor | University of Haifa Academic / other |
| Locations | 1 site (Tel Aviv) |
| Status | Recruiting |
| Started | February 1, 2025 |
| Main results expected | February 1, 2027 |
| Study ends | March 28, 2027 |
| Registry record updated | April 29, 2026 |
| Trial ID | NCT07367750 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are community-dwelling adults (age 21+) in Israel with at least one documented chronic condition, fluent in Hebrew, including kidney transplant recipients and cancer survivors.
✕Probably not a fit
People with documented cognitive impairment, major psychiatric disorders, recent hospitalization (past 3 months), or those not fluent in Hebrew or without reliable internet access are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This mixed-methods pilot delivers the Chronic Disease Self-Management Program (CDSMP) in Hebrew to adults with chronic conditions recruited from a major tertiary center in Tel Aviv. Participants join weekly 2.5-hour online group sessions for six weeks led by certified facilitators, focusing on symptom management, action planning, medication adherence, physical activity, and communication with clinicians. The study collects validated self-report measures before the program, immediately after, and six months later, plus qualitative feedback to gauge feasibility and acceptability. Results will inform whether the CDSMP can be implemented more broadly for kidney transplant recipients and cancer survivors in Israel.
Why it matters
Potential benefit: If successful, participants may gain confidence and practical skills that reduce symptoms, improve daily functioning, and help them manage care more effectively.
How similar studies have gone: The CDSMP is an internationally validated program with evidence of improved self-efficacy and health behaviors, and this pilot tests its feasibility for Israeli patients.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 21 years or older * Diagnosed with at least one chronic disease (as documented in the medical record) * Community-dwelling * Fluent in Hebrew Exclusion Criteria: * Documented cognitive impairment * Diagnosis of major depression or other psychiatric disorder (based on self-report or medical records) * Hospitalization in the past 3 months
Where it's running
-
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel Recruiting
Study contacts
- Principal investigator: Galit Yogev-Seligmann — University of Haifa
- Study coordinator: Galit Yogev-Seligmann
- Email: galit.yogev@gmail.com
- Phone: +972535315761
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Italian Registry of Pediatric Dialysis: collecting data from kids on kidney replacement therapy
This registry in Italy tests how collecting epidemiological, clinical, and treatment data from children on dialysis or pre-emptive kidney transplants can help centers share protocols and improve care.
-
Need-based cancer survivorship program implementation
This project tests a need-based survivorship program for adults who have finished cancer treatment to see if targeted screenings and referrals can help manage symptoms and weight concerns.
-
AI-powered personalized heat risk alerts for adults with chronic conditions
A smartphone app-based test will see if AI-driven, personalized heat risk alerts reduce heat-related illness symptoms in adults with chronic diseases.
-
Intraoperative diuretics during deceased-donor kidney transplants
This trial tests whether using furosemide or mannitol during kidney transplant surgery affects delayed graft function in adults receiving a deceased-donor kidney.
-
Mobile reminder app to help people with chronic disease and memory loss stick to their meds
This study tests whether a smartphone reminder app can improve how well adults with chronic diseases and memory impairment take their prescribed medications.
-
Bridging psychosocial care after cancer treatment
This study tests a routine digital distress screen plus a psycho-oncology navigation call to help cancer survivors access support after completing treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.